Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,855.90
+6.00 (0.32%)
Sep 25, 2026, 3:15 PM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.44 trillion as of September 25, 2026. Its market cap has increased by 13.69% in one year.
Market Cap
4.44T
Enterprise Value
4.15T
Revenue
599.11B
Ranking
n/a
PE Ratio
36.70
Stock Price
1,855.90
ChartMarket Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.44T, an increase of 15,975.40%. That is a compound annual growth rate of 21.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.44T | 7.57% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.48T |
| Zydus Lifesciences | 1.16T |
| Cipla | 1.12T |
| Laurus Labs | 1.08T |
| Mankind Pharma | 1.02T |
| Aurobindo Pharma | 978.14B |
| Glenmark Pharmaceuticals | 694.61B |
| Alkem Laboratories | 637.46B |